CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, has announced a collaboration with Imperial College London, a world-class research university. The research will harness CN Bio’s Liver-on-Chip technology to advance the...
Cambridge Intelligence, creators of data visualization technologies that make the world safer, today announced KronoGraph: a new way to build scalable timeline visualizations.
A digital platform showing plans for Cambridge North has been launched, along with a Twitter account for the development project.
Top 100 law firm, Birketts, has announced the appointment of 15 new trainee solicitors.
Leading law firm, BDB Pitmans, has strengthened its private real estate offering with the addition of new partner Tim Middleton. The appointment has been effective since 1st September 2020.
EBCam hosts a free interactive online event for HR and Finance professionals.
A story with a garden as the main character has finally blossomed into a published novel, years after its first draft was completed as part of a Creative Writing PhD.
The Henry Royce Institute for advanced materials research and innovation celebrated a key milestone earlier this year ahead of the new national hub becoming fully operational in 2021.
Medovate, the Cambridge based medical device development company, has concluded a distribution agreement with Brisbane-based LTR Medical which will provide exclusivity for SAFIRA® (SAFer Injection for Regional Anaesthesia) in Australia and New Zealand.
Check out 1plex's newly refurbished demo facility room - perfect for setting up meetings in this current environment.
PragmatIC, a world leader in flexible electronics, has appointed Erik Langaker as independent Chair to complement its existing strong Board of Directors. This appointment comes alongside additional funding of over £13 million to support ongoing production ramp-up, accelerate manufacturing optimisation and drive continued product innovation.
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and XtalPi Inc., a leading algorithm-driven artificial intelligence (AI)-based pharmaceutical technology company, today announced they have entered into a drug discovery collaboration agreement. Financial details are not disclosed.
Cycle Pharmaceuticals, a privately-owned, global, patient-dedicated biotechnology company focused on developing and delivering medicines for rare diseases, announced that it has executed a definitive agreement for a $25 million credit facility with Deutsche Bank AG.
Cambridge Network today presents CN eLearning – a new suite of digital resources which offers a catalogue of bite-sized courses covering a diverse spectrum of essential skills.
ThoughtRiver, the market leader in automated contract review and pre-screening, has today announced $10M (£7.5M) in Series A funding. The round is led by Octopus Ventures, a leading European venture capital firm which invests in technology innovation leaders.
Cambridgeshire mental health charity Illuminate has today launched a range of services to support the growing number of employers concerned about the impact Covid-19 has had on their employee’s mental health.
Amazon today announced a new investment to expand research and development of autonomous delivery technology in the UK with the creation of a new team at its Cambridge development centre.
Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, today announced it has significantly enhanced its global business development capabilities, with additional resources now committed to support key regions in the USA, Europe and Japan.
Before the coronavirus pandemic hit, millions of us spent our working days in an office – it was our norm, with team meetings, in-jokes and water-cooler moments creating our culture. Then, with the advent of lockdown forcing many to work from home, this all changed.
Private sector investment can be a major driver of the UK’s ‘infrastructure revolution’, says the CBI, at a time when public purses have been stretched by unprecedented Covid-19 support measures.